Abcam plc Drug discovery > Basic Research Products & Reviews

Human Complement C3 ELISA kit is a competitive immunoassay designed for the quantitative measurement of Complement C3 in human plasma and serum.

Abcam’s TNF alpha Rat in vitro ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the quantitative measurement of Rat TNF alpha in cell culture supernatants, serum and plasma samples. A monoclonal antibody specific for TNF alpha has been coated onto the wells of the microtiter strips provided. Samples, including standards of known TNF alpha concentrations, control specimens or unknowns are pipetted into these wel…

Knockout achieved by using CRISPR/Cas9, Homozygous: 4 bp deletion in exon 3

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 4

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and Insertion of the selection cassette in exon 2

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 4 and Insertion of the selection cassette in exon 4

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 5

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 6 and Insertion of the selection cassette in exon 6

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 12 and 4 bp deletion in exon 12

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1

Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 2 and 1 bp insertion in exon 2

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 4

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 10

Knockout achieved by using CRISPR/Cas9, Homozygous: 5 bp deletion in exon 3

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 1 and 2 bp insertion in exon 1

Knockout achieved by using CRISPR/Cas9, 11 bp deletion in exon 1 and 1 bp insertion in exon 1

Knockout achieved by using CRISPR/Cas9, Homozygous: 7 bp deletion in exon 7

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp deletion in exon 2

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 3

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 4

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 4 bp insertion in exon 2